Led · Series A · Apr 2026

mbiomics is a Munich-based techbio company building a platform to design, analyze, screen and manufacture defined, large microbial consortia as Live Biotherapeutic Products (LBPs). Its platform combines AI/ML-driven consortia design, proprietary analytical technology, large consortium co-cultivation, and screening capabilities to create pharmaceutical-grade, scalable microbiome therapeutics. The company is advancing a pipeline of indication-specific microbial communities intended to address patient heterogeneity across oncology and other diseases. Its lead candidate, MBX-116, is positioned as an immune checkpoint inhibitor co-therapy for second-line advanced melanoma, with a Phase 1B study planned for 2027. mbiomics is using recent Series A funding to build IND-enabling pharmacology data and accelerate GMP development and manufacturing as it moves into clinical execution. The company also plans to expand its pipeline into indications where the gut microbiome plays a central role, such as autoimmune and neurodegenerative diseases.

Participated · Series A · Jul 2022

IQM Quantum Computers is a Finland-based developer of quantum computing technology. The company is preparing for public listings on Nasdaq and the Helsinki Stock Exchange. Ahead of those listings, IQM secured $146 million in PIPE financing tied to a SPAC combination with Real Asset Acquisition Corp., including a new commitment from Ilmarinen. IQM plans to use the funds to advance its technology and scale commercial operations. The financing strengthens the company’s near-term financial position as it moves toward becoming a public company.

Participated · Equity · Jan 2021

wealthpilot provides a SaaS platform that aggregates customers’ financial information to enable hybrid wealth management and individualized advice from wealth managers. The platform supports aggregation of liquid assets and is being expanded to include additional asset data such as real estate. The company reports €42 billion in assets entered on the platform, a tenfold increase since mid-2018. wealthpilot plans to grow its team—particularly sales—and broaden its product offering following the new funding. The startup previously raised €2.6 million in late 2019. The company is headquartered in Munich. wealthpilot is a Munich-based fintech that provides a hybrid wealth-management SaaS platform for financial advisors, asset managers, family offices, banks and broker pools. The product automates aggregation and analysis of financial data and offers personalized advice and smart scenario analyses for advisors and private customers. The company says it aims to democratise wealth management by making professional family office and financial-planning tools accessible to a broader audience. Users currently rely on the platform to analyse more than €12 billion of financial assets, a total that has tripled since August 2018. The fresh €2.6 million funding will support development of core functions, creation of iOS and Android mobile apps, growth of sales and marketing teams, and internationalisation efforts. Bayern Kapital participated in the round and invested for a second time, citing the company’s strong growth momentum.

Participated · Seed · Jul 2019

IQM is a Finnish quantum computing company building machines and applications intended to tackle complex problems in chemistry, machine learning and climate mitigation. The company says its quantum computers could help reduce greenhouse gas emissions within three to five years for some early use-cases and is already working on battery solutions with a leading car manufacturer. IQM plans to spend the new funding on research in battery technology, quantum chemistry and other areas. Investors named in the latest round include World Fund, the European Innovation Council and Tencent. The deal pushes IQM’s post-money valuation near $1 billion, according to a person familiar with the matter. Coverage notes industry-wide hype and skepticism around quantum startups, and IQM itself cautioned that scientific breakthroughs do not follow a set timeline. IQM develops superconducting quantum processors and provides an integrated full hardware stack for quantum computers, pursuing a co-design approach that pairs hardware development with software collaborators. The company said the fresh funding will support development and commercialization of quantum computers and expand operations in Germany, including a team in Munich. IQM plans to build co-designed quantum computers for commercial applications and install testing facilities for quantum processors. It collaborates with Finnish research and academic partners such as VTT, Aalto University, and CSC. The company has been rapidly hiring and says it intends to recruit “one quantum engineer per week” as it scales. IQM’s recent funding increases its total raised capital to over €32M. IQM develops high-speed quantum processors and hardware systems aimed at reducing the error rates that limit quantum computers. The company is advancing innovations in thermal management and other areas to improve computational speed and information accuracy. It intends its hardware work to enable a large-scale quantum computing solution for practical applications. IQM plans to use new capital to build infrastructure, recruit talent, and expand collaborations with ecosystem partners. Leadership includes Dr. Jan Goetz (CEO), Dr. Juha Vartiainen (COO), Prof. Mikko Möttönen (Chief Scientist) and Dr. Kuan Tan (CTO). The article reports a US$13M seed raise to fund these efforts.

Participated · Equity · Aug 2018

GWA Hygiene, founded in 2015 and based in Stralsund, Germany, develops NosoEx®, an IoT‑based electronic monitoring system and digital assistant for hand hygiene and infection control in hospitals. NosoEx provides detailed data reports on disinfection of equipment and the general environment and can integrate sensor technology into existing hospital infrastructure. The company employs more than 30 people and has run pilot projects, including a 2021 neonatal ICU pilot, with NosoEx projects already running with partners in several European countries. GWA positions its technology as a response to rising hospital infections and staff shortages by optimizing hygiene processes to allow more time for patient care. The company says fresh capital will be invested in further development of digital hygiene solutions, sales, and intensified roll‑out across Europe. Prior funding includes investments from MIG Fonds and High‑Tech Gründerfonds, the latter having invested several million euros since 2018. GWA Hygiene has developed NosoEx, an IoT monitoring system that measures hand hygiene by fitting sensors to existing disinfectant dispensers and reporting disinfection figures by station, dispenser and occupational group. The software integrates with health-facility infrastructure to track and display hygiene metrics. The system has passed practical tests and is already used across around 70 wards in 10 hospitals, with a double-digit number of customers in the DACH region. The company is in talks with about 50 other hospitals and hospital operators and is preparing a Europe-wide roll-out. GWA intends to use the new funding to establish a sales organization to accelerate commercial adoption. The startup was founded in 2015 and has 21 employees, led by Founder and Managing Director Maik Gronau alongside founding partners Tobias Gebhardt, Dirk Amtsberg, Marcel Walz and Daniel Neuendorf.